SymBio Pharmaceuticals Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY78.19 |
Market Cap |
JPY9.63 B |
Shares Outstanding |
74.64 M |
Public Float |
65.41 M |
Address |
Toranomon 30 Mori Building Tokyo Tokyo 105 Japan |
Employees | - |
Website | http://www.symbiopharma.com |
Updated | 09/14/2018 |
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded on March 25, 2005 by Fuminori Yoshida and is headquartered in Tokyo, Japan. |